BIOSERGEN AB
BIOSERGEN AB
Share · SE0016013460 · A3CSG0 (XSTO)
Overview
No Price
Closing Price XSTO 30.01.2026: 42,00 SEK
30.01.2026 15:44
Current Prices from BIOSERGEN AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
BIOSGN.ST
SEK
30.01.2026 15:44
42,00 SEK
-2,60 SEK
-5,83 %
Share Float & Liquidity
Free Float 57,73 %
Shares Float 1,36 M
Shares Outstanding 2,35 M
Company Profile for BIOSERGEN AB Share
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.
AI Analysis of BIOSERGEN AB
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of BIOSERGEN AB
No AI threads available for this company yet.

Company Data

Name BIOSERGEN AB
Company Biosergen AB
Website https://biosergen.net
Primary Exchange XSTO Frankfurt
WKN A3CSG0
ISIN SE0016013460
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Tine Kold Olesen
Market Capitalization 94 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Fogdevreten 2, 171 65 Solna
IPO Date 2021-06-24

Stock Splits

Date Split
01.12.2025 1:100

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB BIOSGN.ST
Frankfurt 8N1.F
More Shares
Investors who hold BIOSERGEN AB also have the following shares in their portfolio:
AFRICA OIL CORP
AFRICA OIL CORP Share
FRATEMSP500SETF DLA
FRATEMSP500SETF DLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026